The Relationship between Serum Zonulin Level and Clinical and Laboratory Parameters of Childhood Obesity

Tuncay Küme, Sezer Acar, Hale Tuhan

  • 1Dokuz Eylül University Faculty of Medicine, Department of Pediatric Endocrinology, İzmir, Turkey Phone: +90 232 412 60 76

Insights

Childhood obesity is linked to higher zonulin levels, a marker of gut permeability. This study suggests zonulin may play a role in obesity development and related metabolic issues in children.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Gastroenterology

Background:

  • Childhood obesity is a growing global health concern.
  • Obesity is associated with metabolic disturbances, including insulin resistance.
  • Intestinal permeability, indicated by zonulin levels, is increasingly recognized as a factor in metabolic health.

Purpose of the Study:

  • To examine the association between zonulin levels and clinical and laboratory markers in obese children.
  • To explore the relationship between zonulin, insulin resistance, and leptin in pediatric obesity.

Main Methods:

  • A cross-sectional study comparing obese children (BMI >95th percentile) with healthy controls.
  • Measurement of various clinical parameters (BMI, blood pressure, body fat percentage) and biochemical markers (glucose, insulin, lipids, zonulin, leptin).

Main Results:

  • Obese children exhibited significantly higher levels of insulin, HOMA-IR, triglycerides, total cholesterol, LDL-C, HDL-C, zonulin, and leptin compared to healthy children.
  • No significant difference in glucose levels was observed between the groups.
  • Zonulin levels correlated negatively with HDL-C and positively with leptin levels in obese children, after adjusting for age and BMI.

Conclusions:

  • This study is the first to investigate circulating zonulin in relation to insulin resistance and leptin in childhood obesity.
  • Elevated zonulin levels in obese children suggest a potential role in the pathogenesis of obesity and associated metabolic dysregulation.
  • Zonulin may serve as a biomarker for intestinal permeability and metabolic disturbances in pediatric obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
564
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
336
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
321
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
726